Replies to post #97437 on Biotech Values

[Biowatch]

OT Pretty in Pink

[turtlepower]

Boehringer Ends Female Desire Drug Development After FDA's Safety Query
By Naomi Kresge - Oct 8, 2010 3:55 AM ET
Tweet LinkedIn Share Print Email
Oct. 8 (Bloomberg) - Boehringer Ingelheim GmbH abandoned development of its female desire drug flibanserin after U.S. regulators said the pill wasn’t proven to be safe and effective.

<snip>
http://www.bloomberg.com/news/2010-10-08/boehringer-ends-female-desire-drug-development-after-fda-s-safety-query.html?